.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Boehringer Ingelheim
Johnson and Johnson
Daiichi Sankyo
Fish and Richardson
Cipla
Teva
US Army
Fuji
McKesson

Generated: September 21, 2017

DrugPatentWatch Database Preview

Hydroflumethiazide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hydroflumethiazide and what is the scope of hydroflumethiazide freedom to operate?

Hydroflumethiazide
is the generic ingredient in seven branded drugs marketed by Watson Labs, Shire Llc, Par Pharm, Wyeth Ayerst, Ivax Pharms, Shire, and Usl Pharma, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for hydroflumethiazide.

Summary for Generic Name: hydroflumethiazide

Tradenames:7
Patents:0
Applicants:7
NDAs:11
Drug Master File Entries: see list2
Bulk Api Vendors: see list39
Clinical Trials: see list1
Patent Applications: see list4,409
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:hydroflumethiazide at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm
HYDROFLUMETHIAZIDE
hydroflumethiazide
TABLET;ORAL088850-001May 31, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Shire
SALUTENSIN-DEMI
hydroflumethiazide; reserpine
TABLET;ORAL012359-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Pharms
RESERPINE AND HYDROFLUMETHIAZIDE
hydroflumethiazide; reserpine
TABLET;ORAL088932-001Jan 11, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Shire
SALUTENSIN
hydroflumethiazide; reserpine
TABLET;ORAL012359-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
HYDROFLUMETHIAZIDE
hydroflumethiazide
TABLET;ORAL088031-001Apr 6, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
DIUCARDIN
hydroflumethiazide
TABLET;ORAL083383-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
HYDROFLUMETHIAZIDE AND RESERPINE
hydroflumethiazide; reserpine
TABLET;ORAL088127-001Mar 22, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
RESERPINE AND HYDROFLUMETHIAZIDE
hydroflumethiazide; reserpine
TABLET;ORAL088907-001Sep 20, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Usl Pharma
HYDROFLUMETHIAZIDE AND RESERPINE
hydroflumethiazide; reserpine
TABLET;ORAL088195-001Oct 26, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
HYDROFLUMETHIAZIDE
hydroflumethiazide
TABLET;ORAL088528-001Aug 15, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Mallinckrodt
Argus Health
Chubb
Johnson and Johnson
QuintilesIMS
Novartis
Colorcon
Healthtrust
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot